Device Trial Radar · NCT02321514
Expanded Clinical Study of the Tendyne Mitral Valve System
Last checked: Nov 20, 2026Latest source record: Jul 17, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
191
Actual
Start
Nov 2014
Primary completion
Jul 2020
Study completion Apr 2025
Sponsor
- Lead sponsor
- Abbott Medical DevicesPublic (ABT)
- Sponsor type
- Industry
- First posted
- Dec 22, 2014
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the safety and performance of the Tendyne Mitral Valve System in the treatment of severe mitral regurgitation in patents with functional disability greater than or equal to NYHA Class II, who are not suitable candidates for surgical replacement with otherwise available devices. Follow-up evaluations will be conducted through 5 years post implantation.
Conditions
- Mitral Valve Regurgitation
Interventions
Tendyne Mitral Valve SystemDevice
Patients will undergo transcatheter mitral valve replacement using Tendyne Mitral Valve system
Primary outcomes
What the sponsor says the trial is designed to measure.
- Safety Endpoint: Number of Participants With Composite of Device Success and Freedom From Device or Procedure Related Serious Adverse Events (SAEs)Time frame: 30 days post-index procedure
- Performance Endpoint: Number of Participants With MR Grade ≤ 2Time frame: 30 days post-index procedure
Locations
40 sites in 10 countries. Site status is shown where the registry gives one.
Honor Health Scottsdale Shea Medical Center
Scottsdale, Arizona
MedStar Washington Hospital
Washington D.C., District of Columbia
Morton Plan Mease Health Care
Clearwater, Florida
37 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.